Partially-covered stent placement versus surgical gastrojejunostomy for the palliation of malignant gastroduodenal obstruction secondary to pancreatic cancer
Jiaywei Tsauo(Ulsan College), Do Hoon Kim(Ulsan College), Dae Wook Hwang(Asan Medical Center), Song Cheol Kim(Ulsan College), Min‐Hee Ryu(Ulsan College), Jin Hyoung Kim(Asan Medical Center), Jeong Hoon Lee(Ulsan College), Jung‐Hoon Park(Macrogen (South Korea)), Kee Don Choi(Asan Medical Center), Ho-Young Song(Ulsan College), Moon‐Won Yoo(Ulsan College)
Cited by 18
Related Papers
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299